On January 6, 2022, the Board of Directors of Emmaus Life Sciences, Inc. expanded the number of directors from seven to eight and appointed Lori Teranishi as a director of the company.  Ms. Teranishi is also expected to be appointed to serve on one or more of the standing Committees of the Board when her schedule permits. Ms. Teranishi is the founder and Chief Executive Officer of iQ 360. Before founding iQ 360 in 2010, Ms. Teranishi oversaw product development as a vice president at Visa, where she launched a global loyalty program and other consumer and B2B products.

She also served as chief of staff to Visa's chief operating officer, managing business planning for the company, and prior to that role, had responsibility for variety of communications functions.